Eli Lilly and Company today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study evaluated orforglipron, an investigational, once-daily oral small molecule ...
Companies like CH Biotech are really pushing the envelope with new ideas. They’re looking at everything from how to make ...
The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback